Amedeo Smart

Free Medical Literature Service

 

Amedeo

Cervical Cancer
  Free Subscription

Articles published in
Oncol Rep
    April 2024
  1. SHI C, Zhang Z
    [Retracted] MicroRNA?362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.
    Oncol Rep. 2024;51:54.
    >> Share

    December 2023
  2. LIU Z, Zhang H, Hu X
    Analysis of the expression and mechanism of follistatin?like protein 1 in cervical cancer.
    Oncol Rep. 2023;50:215.
    >> Share

    November 2023
  3. LIANG H, Luo R, Chen X, Zhao Y, et al
    [Retracted] miR?187 inhibits the growth of cervical cancer cells by targeting FGF9.
    Oncol Rep. 2023;50:195.
    >> Share

    July 2023
  4. LI M, Gao Z, Wang S, Zhao Y, et al
    miR‑27a‑3p upregulation by p65 facilitates cervical tumorigenesis by increasing TAB3 expression and is involved in the positive feedback loop of NF‑kappaB signaling.
    Oncol Rep. 2023;50:132.
    >> Share

    June 2023
  5. YANG J, Gao Y, Yao S, Wan S, et al
    TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1.
    Oncol Rep. 2023;49:114.
    >> Share

  6. NDIAYE M, Diop G, Derbois C, Spadoni JL, et al
    Gene expression profiling of peripheral blood mononuclear cells from women with cervical lesions reveals new markers of cancer.
    Oncol Rep. 2023;49:118.
    >> Share

    May 2023
  7. CAUSIN RL, Van Helvoort Lengert A, Gomes INF, De Freitas AJA, et al
    MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression.
    Oncol Rep. 2023;49:109.
    >> Share

    February 2023
  8. GAO Y, Ma X, Lu H, Xu P, et al
    PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer.
    Oncol Rep. 2023;49:25.
    >> Share

    January 2023
  9. CHEN D, Cao J, Tian L, Liu F, et al
    [Retracted] Induction of apoptosis by casticin in cervical cancer cells through reactive oxygen species‑mediated mitochondrial signaling pathways.
    Oncol Rep. 2023;49:11.
    >> Share

    November 2022
  10. RAMLI I, Susworo S, Nuranna L, Mansyur M, et al
    Circadian as a prognostic factor for radiation responses in patients with cervical cancer: A nested casecontrol study.
    Oncol Rep. 2022;48.
    >> Share

  11. ZHOU L, Li H, Zhang D, Chen L, et al
    OTX1 promotes tumorigenesis and progression of cervical cancer by regulating the Wnt signaling pathway.
    Oncol Rep. 2022;48.
    >> Share

    October 2022
  12. LIU C, Feng H, Song L, Li S, et al
    Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer.
    Oncol Rep. 2022;48.
    >> Share

  13. XING F, Song Z, Cheng Z
    High expression of PDIA4 promotes malignant cell behavior and predicts reduced survival in cervical cancer.
    Oncol Rep. 2022;48.
    >> Share

    September 2022
  14. WANG Z, He S, Guo P, Guo X, et al
    [Retracted] MicroRNA1297 inhibits metastasis and epithelialmesenchymal transition by targeting AEG1 in cervical cancer.
    Oncol Rep. 2022;48.
    >> Share

  15. LIAO H, Pan Y, Pan Y, Shen J, et al
    [Retracted] MicroRNA874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1.
    Oncol Rep. 2022;48.
    >> Share

    May 2022
  16. XIAO W, Zhou S, Xu H, Li H, et al
    [Corrigendum] NogoB promotes the epithelialmesenchymal transition in HeLa cervical cancer cells via Fibulin5.
    Oncol Rep. 2022;47.
    >> Share

    April 2022
  17. ZHANG W, Wang C, Hu X, Lian Y, et al
    Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells.
    Oncol Rep. 2022;47.
    >> Share

    December 2021
  18. ZHAO Q, Zhai YX, Liu HQ, Shi YA, et al
    [Retracted] MicroRNA4915p suppresses cervical cancer cell growth by targeting hTERT.
    Oncol Rep. 2021;46.
    >> Share

    November 2021
  19. LI Y, Qian X, Lin Y, Tao L, et al
    Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
    Oncol Rep. 2021;46.
    >> Share

  20. LIU L, Shi W, Xiao X, Wu X, et al
    BCG immunotherapy inhibits cancer progression by promoting the M1 macrophage differentiation of THP1 cells via the Rb/E2F1 pathway in cervical carcinoma.
    Oncol Rep. 2021;46.
    >> Share

    July 2021
  21. SONG X, Shi B, Huang K, Zhang W, et al
    [Retracted] miR133a inhibits cervical cancer growth by targeting EGFR.
    Oncol Rep. 2021;46.
    >> Share

  22. CHU J, Gao J, Wang J, Li L, et al
    Mechanism of hydrogen on cervical cancer suppression revealed by highthroughput RNA sequencing.
    Oncol Rep. 2021;46.
    >> Share

    June 2021
  23. DEZEN T, Rossini RR, Spadin MD, Da Cunha Andrade CEM, et al
    Accuracy of MRI for diagnosing pelvic and paraaortic lymph node metastasis in cervical cancer.
    Oncol Rep. 2021;45.
    >> Share

    May 2021
  24. WANG J, Xiang F, Liu X, Ma X, et al
    HPV E7 affects the function of cervical cancer cells via the TAL1/lncEBIC/KLHDC7B axis.
    Oncol Rep. 2021;45.
    >> Share

  25. YANG X, Du H, Bian W, Li Q, et al
    FOXD3AS1/miR1283p/LIMK1 axis regulates cervical cancer progression.
    Oncol Rep. 2021;45.
    >> Share

  26. OUYANG F, Liu J, Xia M, Lin C, et al
    [Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in earlystage cervical cancer.
    Oncol Rep. 2021;45.
    >> Share

    April 2021
  27. YOU X, Wang Y, Meng J, Han S, et al
    Exosomal miR663b exposed to TGFbeta1 promotes cervical cancer metastasis and epithelialmesenchymal transition by targeting MGAT3.
    Oncol Rep. 2021;45:1.
    >> Share

  28. CHEN J, Chen H, Pan L
    SIRT1 and gynecological malignancies (Review).
    Oncol Rep. 2021;45.
    >> Share

    March 2021
  29. QIN K, Jian D, Xue Y, Cheng Y, et al
    DDX41 regulates the expression and alternative splicing of genes involved in tumorigenesis and immune response.
    Oncol Rep. 2021;45:1213-1225.
    >> Share

    February 2021
  30. SHEN Z, Song W, Qian L, Zhu J, et al
    Effect of claudin 1 on cell proliferation, migration and apoptosis in human cervical squamous cell carcinoma.
    Oncol Rep. 2021;45:606-618.
    >> Share

    November 2020
  31. LIU H, Li Y, Zhang J, Wu N, et al
    ErbB2 Receptor Tyrosine Kinase 2 is negatively regulated by the p53responsive microRNA31845p in cervical cancer cells.
    Oncol Rep. 2020 Nov 19. doi: 10.3892/or.2020.7862.
    >> Share

    October 2020
  32. WANG A, Liu L, Yuan M, Han S, et al
    Role and mechanism of FLNa and UCP2 in the development of cervical cancer.
    Oncol Rep. 2020 Oct 21. doi: 10.3892/or.2020.7819.
    >> Share

    July 2020
  33. SI J, Zhang J, Gan L, Guo M, et al
    The effects of the Wnt/betacatenin signaling pathway on apoptosis in HeLa cells induced by carbon ion irradiation.
    Oncol Rep. 2020;44:303-312.
    >> Share

    May 2020
  34. MA HR, Cao L, Wang F, Cheng C, et al
    Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells.
    Oncol Rep. 2020;43:1536-1546.
    >> Share

    April 2020
  35. ICHIKAWA R, Kawasaki R, Iwata A, Otani S, et al
    MicroRNA1263p suppresses HeLa cell proliferation, migration and invasion, and increases apoptosis via the PI3K/PDK1/AKT pathway.
    Oncol Rep. 2020;43:1300-1308.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016